tiprankstipranks

Catherine Sohn Insider Profile

4 Followers
Catherine Sohn, Director at Jazz Pharmaceuticals, holds 14.87K shares in Jazz Pharmaceuticals (Ticker: JAZZ), holds 54.07K shares in Lifecore Biomedical (Ticker: LFCR), holds 1.00K shares in Axcella Health (Ticker: AXLA).
tipranks
Catherine Sohn

Catherine Sohn
Jazz Pharmaceuticals (JAZZ)
Director

Ranked #37,091 out of 98,564 Corporate Insiders

Profitable Transactions

60%
12 out of 20 Profitable Transactions

Average Return

+0.80%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$3M
62.41%
24.24%
13.35%
0.00%
A breakdown of Catherine Sohn's holdings

Insider Roles

Jazz Pharmaceuticals
(JAZZ)
Director
Palisade Bio
(PALI)
Director
Lifecore Biomedical
(LFCR)
Director
Altimmune
(ALT)
Director
Roles that Catherine Sohn holds in companies

Most Profitable Insider Trade

Stock:
Lifecore Biomedical
(LFCR)
Rating:Informative Buy
Date:Jun 10, 2014 - Jun 10, 2015
Return:+26.90%
The most profitable trade made by Catherine Sohn

Catherine Sohn's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Jazz Pharmaceuticals
Aug 15, 2023
Director
Uninformative Buy
$1.63M
RUBY
Rubius Therapeutics
Jul 23, 2018
Informative Buy
57.50K
$142.50
AXLA
Axcella Health
Jan 21, 2020
Informative Buy
4.87K
$400.00
Altimmune
Director
Palisade Bio
Jul 06, 2015
Director
Uninformative Buy
$633.16K
Lifecore Biomedical
Jun 07, 2022
Director
Uninformative Buy
67.06K
$348.75K
List of latest transactions for each holding click on a transaction to see Catherine Sohn's performance on stock

Catherine Sohn insider profile FAQ

What is the percentage of profitable transactions made by Catherine Sohn?
The percentage of profitable transactions made by Catherine Sohn is 60%.
    What is the average return per transaction made by Catherine Sohn?
    The average return per transaction made by Catherine Sohn is 0.80%.
      What stocks does Catherine Sohn hold?
      Catherine Sohn holds: JAZZ, RUBY, AXLA, ALT, PALI, LFCR stocks.
        What was Catherine Sohn’s latest transaction?
        Catherine Sohn latest transaction was an Uninformative Buy of ―.
          What was Catherine Sohn's most profitable transaction?
          Catherine Sohn’s most profitable transaction was an Informative Buy of LFCR stock on June 10, 2014. The return on the trade was 26.90%.
            What is Catherine Sohn's role in Jazz Pharmaceuticals?
            Catherine Sohn's role in Jazz Pharmaceuticals is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.